Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2017-2028

2.1.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Segment by Type

2.2.1 BP-101

2.2.2 Bremelanotide

2.2.3 Gepirone Hydrochloride ER

2.2.4 PVT-011

2.2.5 Others

2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type

2.3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Female Hypoactive Sexual Desire Disorder Therapeutics Segment by Application

2.4.1 Out-Patient

2.4.2 In-Patient

2.5 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application

2.5.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Player

3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Players

3.1.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Female Hypoactive Sexual Desire Disorder Therapeutics by Regions

4.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth (2017-2022)

4.3 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth (2017-2022)

4.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022)

5.2 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022)

5.3 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2017-2022)

6.2 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022)

6.3 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics by Country (2017-2022)

7.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022)

7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Forecast

10.1.3 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Forecast

10.1.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Forecast

10.1.5 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Forecast

10.2 Americas Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.2.2 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.2.3 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.2.4 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3 APAC Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Region (2023-2028)

10.3.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3.2 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3.3 Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3.4 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3.5 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.3.6 Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.4.2 France Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.4.3 UK Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.4.4 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.4.5 Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.5 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.5.2 South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.5.3 Israel Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.5.4 Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.5.5 GCC Countries Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast

10.6 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Type (2023-2028)

10.7 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Emotional Brain BV

11.1.1 Emotional Brain BV Company Information

11.1.2 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

11.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Emotional Brain BV Main Business Overview

11.1.5 Emotional Brain BV Latest Developments

11.2 GlaxoSmithKline Plc

11.2.1 GlaxoSmithKline Plc Company Information

11.2.2 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

11.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GlaxoSmithKline Plc Main Business Overview

11.2.5 GlaxoSmithKline Plc Latest Developments

11.3 Palatin Technologies Inc

11.3.1 Palatin Technologies Inc Company Information

11.3.2 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

11.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Palatin Technologies Inc Main Business Overview

11.3.5 Palatin Technologies Inc Latest Developments

11.4 Pivot Pharmaceuticals Inc

11.4.1 Pivot Pharmaceuticals Inc Company Information

11.4.2 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

11.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pivot Pharmaceuticals Inc Main Business Overview

11.4.5 Pivot Pharmaceuticals Inc Latest Developments

11.5 Strategic Science & Technologies LLC

11.5.1 Strategic Science & Technologies LLC Company Information

11.5.2 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

11.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Strategic Science & Technologies LLC Main Business Overview

11.5.5 Strategic Science & Technologies LLC Latest Developments

12 Research Findings and Conclusion

Table 1. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of BP-101

Table 3. Major Players of Bremelanotide

Table 4. Major Players of Gepirone Hydrochloride ER

Table 5. Major Players of PVT-011

Table 6. Major Players of Others

Table 7. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 10. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Player (2020-2022)

Table 15. Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Products Offered

Table 16. Female Hypoactive Sexual Desire Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Regions (2017-2022)

Table 21. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Country (2017-2022)

Table 23. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 25. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 27. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Region (2017-2022)

Table 29. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 31. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 33. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Country (2017-2022)

Table 35. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 37. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Female Hypoactive Sexual Desire Disorder Therapeutics

Table 46. Key Market Challenges & Risks of Female Hypoactive Sexual Desire Disorder Therapeutics

Table 47. Key Industry Trends of Female Hypoactive Sexual Desire Disorder Therapeutics

Table 48. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 54. Emotional Brain BV Details, Company Type, Female Hypoactive Sexual Desire Disorder Therapeutics Area Served and Its Competitors

Table 55. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

Table 56. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Emotional Brain BV Main Business

Table 58. Emotional Brain BV Latest Developments

Table 59. GlaxoSmithKline Plc Details, Company Type, Female Hypoactive Sexual Desire Disorder Therapeutics Area Served and Its Competitors

Table 60. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

Table 61. GlaxoSmithKline Plc Main Business

Table 62. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. GlaxoSmithKline Plc Latest Developments

Table 64. Palatin Technologies Inc Details, Company Type, Female Hypoactive Sexual Desire Disorder Therapeutics Area Served and Its Competitors

Table 65. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

Table 66. Palatin Technologies Inc Main Business

Table 67. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Palatin Technologies Inc Latest Developments

Table 69. Pivot Pharmaceuticals Inc Details, Company Type, Female Hypoactive Sexual Desire Disorder Therapeutics Area Served and Its Competitors

Table 70. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

Table 71. Pivot Pharmaceuticals Inc Main Business

Table 72. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Pivot Pharmaceuticals Inc Latest Developments

Table 74. Strategic Science & Technologies LLC Details, Company Type, Female Hypoactive Sexual Desire Disorder Therapeutics Area Served and Its Competitors

Table 75. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product Offered

Table 76. Strategic Science & Technologies LLC Main Business

Table 77. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Strategic Science & Technologies LLC Latest Developments

List of Figures

Figure 1. Female Hypoactive Sexual Desire Disorder Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 7. Female Hypoactive Sexual Desire Disorder Therapeutics in Out-Patient

Figure 8. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market: Out-Patient (2017-2022) & ($ Millions)

Figure 9. Female Hypoactive Sexual Desire Disorder Therapeutics in In-Patient

Figure 10. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market: In-Patient (2017-2022) & ($ Millions)

Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Player in 2021

Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 15. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 16. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Value Market Share by Country in 2021

Figure 19. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Market Share by Type in 2021

Figure 20. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 21. United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Region in 2021

Figure 26. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 27. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Country in 2021

Figure 34. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 35. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 36. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Market Share by Application in 2021

Figure 44. Egypt Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 50. APAC Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 51. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. UK Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Spain Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Israel Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Female Hypoactive Sexual Desire Disorder Therapeutics Market Size 2023-2028 ($ Millions)